EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis

EDUARDO MUÑOZ BLANCOMARCO ANTONIO CALZADO CANALE2026-01-292026-01-29201810.1016/j.bcp.2018.07.0472-s2.0-85051059089https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/29434BiochemistryPharmacologyEHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosisresearch article